Results for Arterial Angioplasty

1 - 5 of 5

Dr. Levy is the director of Cardiology Research, and also serves as program director of the Cardiology National Heart, Lung, and Blood Institute (NHLBI) Research Training Grant. His research interests are the pathophysiology of biomaterials used in medicine, basic mechanisms and novel therapies for heart valve disease, arterial angioplasty, local drug delivery, and nanomedicine. He also has experience over three decades in medical device development.

E-mail:

levyr [at] chop.edu

Michael Chorny, PhD

Dr. Chorny's research program focuses on nanomedicines as well as drug, cell, and gene delivery systems for treating proliferative disease. His current research specifically focuses on the use of nanoparticle-mediated delivery to solid tumors and site-specific delivery for cardiovascular disease.

E-mail:

chorny [at] chop.edu

Levy Laboratory

Research in the Levy Lab centers on the pathophysiology of biomaterials used in medicine, basic mechanisms and novel therapies for heart valve disease, arterial angioplasty, local drug delivery, and nanomedicine.

Chorny Laboratory

The laboratory led by Michael Chorny, PhD, designs delivery systems for drugs and biotherapeutics, focusing on vascular proliferative diseases and high-risk malignancies. Biodegradable nanoparticles and prodrugs are optimized to enhance and extend therapeutic activity, and minimize adverse effects.

Division of Interventional Radiology

Interventional RadiologyInterventional Radiology

Providing state-of-the-art interventional radiology research aimed at safety and quality, percutaneous oncologic therapies, MR-guided intervention, and 3D-printed device technology.